Inga Nehlmeier

7PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infectious agentsSpeciation and extinctionCarbon capture engineering (excl. sequestration)Agricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
JN.1-adapted vaccination is associated with readjustment of ancestral memory B cells toward neutralization within the JN.1 antigenic space.

|Jun 13, 2023
Omicron subvariant BA.5 efficiently infects lung cells.

Markus Hoffmann, Lok-Yin Roy Wong, Prerna Arora

|May 08, 2023
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage.

Inga Nehlmeier, Amy Kempf, Prerna Arora

|Mar 03, 2023
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5.

Markus Hoffmann, Prerna Arora, Inga Nehlmeier

|May 17, 2022
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.

Prerna Arora, Amy Kempf, Inga Nehlmeier

|Jan 05, 2022
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.

Prerna Arora, Amy Kempf, Inga Nehlmeier

Pageof 2

Frequent Collaborators

7 joint publications

Stefan Pöhlmann

7 joint publications

Markus Hoffmann

5 joint publications

Sebastian Schulz

5 joint publications

Georg M N Behrens